DERM
Journey Medical Corp.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$4.73
+1.94%Forward multiples
Based on analyst estimates
- P/E forward
- 15.77x
- P/E 2026E
- —
- P/E 2027E
- 10.59x
- P/E 2028E
- 4.46x
- P/S forward
- 1.21x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.16x
- Price / sales
- 1.96x
- Price / cash flow
- -17.82x
Enterprise value
- Enterprise value
- $133.4M
- EV / sales
- 1.96x
- EV / EBITDA
- 71.30x
- EV / EBIT
- -44.35x
- Market cap
- $133.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026